Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Bioflight A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   0.6% 0.6% 0.6% 0.6% 0.5% 0.6% 6.8% 6.6%   Credit score (0-100)   97 98 96 96 98 96 35 36   Credit rating   AA AA AA AA AA AA BBB BBB   Credit limit (kDKK)   1,521.7 2,697.3 2,709.0 4,216.5 5,664.6 4,619.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,436 14,524 9,496 20,511 23,278 19,465 0.0 0.0   EBITDA   7,855 10,452 6,070 14,423 18,211 13,543 0.0 0.0   EBIT   1,916 10,243 5,528 13,301 16,735 11,644 0.0 0.0   Pre-tax profit (PTP)   1,463.8 9,779.5 5,002.4 12,848.1 16,296.5 10,187.8 0.0 0.0   Net earnings   1,136.4 7,626.5 3,900.2 10,020.8 12,707.2 7,920.1 0.0 0.0   Pre-tax profit without non-rec. items   1,464 9,780 5,002 12,848 16,297 10,188 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   31,859 36,881 42,972 40,430 51,691 69,513 0.0 0.0   Shareholders equity total   12,700 20,327 24,227 33,248 45,955 38,875 27,475 27,475   Interest-bearing liabilities   18,933 14,759 16,874 905 1,128 28,525 0.0 0.0   Balance sheet total (assets)   32,909 37,924 43,927 45,493 55,556 73,866 27,475 27,475   Net Debt   18,930 14,590 16,873 -1,700 1,076 28,246 -27,475 -27,475     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,436 14,524 9,496 20,511 23,278 19,465 0.0 0.0   Gross profit growth   -2.1% 27.0% -34.6% 116.0% 13.5% -16.4% -100.0% 0.0%   Employees   5 6 7 9 10 10 0 0   Employee growth %   0.0% 20.0% 16.7% 28.6% 11.1% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   32,909 37,924 43,927 45,493 55,556 73,866 27,475 27,475   Balance sheet change%   5.9% 15.2% 15.8% 3.6% 22.1% 33.0% -62.8% 0.0%   Added value   7,855.1 10,452.3 6,070.2 14,422.7 17,856.8 13,542.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -3,612 4,812 5,549 -3,664 9,785 15,924 -69,513 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.7% 70.5% 58.2% 64.8% 71.9% 59.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.0% 28.9% 13.5% 29.8% 33.1% 18.0% 0.0% 0.0%   ROI %   6.3% 30.4% 14.0% 33.5% 39.1% 19.5% 0.0% 0.0%   ROE %   9.4% 46.2% 17.5% 34.9% 32.1% 18.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   38.6% 53.6% 55.2% 73.1% 82.7% 52.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   241.0% 139.6% 278.0% -11.8% 5.9% 208.6% 0.0% 0.0%   Gearing %   149.1% 72.6% 69.7% 2.7% 2.5% 73.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.5% 2.8% 3.3% 5.1% 43.2% 9.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.2 0.2 0.5 0.5 0.1 0.0 0.0   Current Ratio   0.2 0.2 0.2 0.5 0.5 0.1 0.0 0.0   Cash and cash equivalent   3.5 168.8 1.8 2,604.1 52.0 278.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,781.4 -4,593.4 -3,059.4 -4,862.6 -3,726.4 -27,585.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,571 1,742 867 1,603 1,786 1,354 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,571 1,742 867 1,603 1,821 1,354 0 0   EBIT / employee   383 1,707 790 1,478 1,674 1,164 0 0   Net earnings / employee   227 1,271 557 1,113 1,271 792 0 0